L3VLUP
ProSign in

TGTX · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

TGTXJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • TGTX
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterTGTXJNJ
Q3 20203 holders, $416m30 holders, $26.2bn
Q4 20207 holders, $1.3bn32 holders, $26.6bn
Q1 20216 holders, $1.4bn31 holders, $25.3bn
Q2 20216 holders, $1.2bn37 holders, $25.6bn
Q3 20214 holders, $893m40 holders, $24.1bn
Q4 20212 holders, $194m33 holders, $25.2bn
Q1 20222 holders, $74m35 holders, $28.2bn
Q2 20222 holders, $29m33 holders, $26.9bn
Q3 20222 holders, $51m36 holders, $25.4bn
Q4 20225 holders, $108m35 holders, $27.6bn
Q1 20233 holders, $55m42 holders, $24.5bn
Q2 20237 holders, $154m38 holders, $25.0bn
Q3 20235 holders, $47m37 holders, $18.9bn
Q4 20232 holders, $36m31 holders, $19.0bn
Q1 20243 holders, $37m32 holders, $19.7bn
Q2 20246 holders, $109m35 holders, $20.4bn
Q3 20246 holders, $94m28 holders, $22.3bn
Q4 20243 holders, $2.7m37 holders, $20.4bn
Q1 20255 holders, $57m32 holders, $20.5bn
Q2 20254 holders, $49m31 holders, $18.4bn
Q3 20256 holders, $102m32 holders, $23.7bn
Q4 20256 holders, $83m29 holders, $27.8bn
Q1 20265 holders, $88m34 holders, $35.6bn
Q2 20268 holders, $445m33 holders, $39.1bn
TGTX

TG Therapeutics Inc

Holders
6
Reported value
$109m
Buyers
6
Sellers
0

Breadth +6 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
JNJ

Johnson & Johnson

Holders
35
Reported value
$20.4bn
Buyers
24
Sellers
8

Breadth +16 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2024

Among the 36 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only TGTX (1)

ExodusPoint Capital Management LP

Only JNJ (30)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Bridgewater Associates LP, Capital Research Global Investors, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), GAMCO Investors Inc, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, and 5 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →